Clinical trial
Validation of the O3 Regional Somatic Tissue Oxygenation Monitor
NCT04584788 · Masimo Corporation, Industry · Completed
Key facts
| NCT number | NCT04584788 |
|---|---|
| Title | Validation of the O3 Regional Somatic Tissue Oxygenation Monitor |
| Official title | A Single-Center, Prospective Study in Healthy Volunteers for Validation of the O3 Regional Somatic Tissue Oxygenation Monitor |
| Lead sponsor | Masimo Corporation, Industry |
| Collaborators | University Medical Center Groningen |
| Status | Completed |
| Study type | Interventional |
| Conditions | Oxygen Deficiency |
| Intervention type | Device |
| Interventions | Masimo O3 Regional Oximeter |
| Enrollment | 37 |
| Start date | Nov 30, 2020 |
| Primary completion | Jun 2, 2021 |
| Completion | Jun 2, 2021 |
| First posted | Oct 14, 2020 |
| Last update posted | Jun 27, 2022 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: